J&J’s test drug for manic episodes in bipolar disorder meets main goal
HQ Team September 22, 2026: American pharmaceutical company Johnson & Johnson’s investigational drug met its main goal during end-stage trials for the treatment.
Drugs
Pharma
Research
Drugs
Health
Pharma
Death toll in Congo’s worst Ebola virus outbreak set to cross 7,000: CDC says
HQ Team September 14, 2026: The death toll from the Ebola virus, which is sweeping through the heart of the Central African region.
Drugs
Health
Pharma
AstraZeneca, Amgen’s drug for nasal inflammation gets EU nod
The European Union approved AstraZeneca Plc and Amgen Inc.’s add-on therapy to treat adults with a chronic inflammatory condition of the nasal passages.
Drugs
Health
Pharma
China’s Innovent, Japan’s Takeda in $11.4 billion deal for cancer therapies
China’s Innovent Biologics and Takeda Pharmaceutical Co. announced a $11.4 billion licensing deal, which will enable the former to speed up the development.
Drugs
Health
Pharma
Zenas, InnoCare in $2b licensing deal for MS, autoimmune diseases
Zenas BioPharma, Inc. and China’s InnoCare Pharma Limited have inked a $2 billion licensing deal that grants the US-based Zenas global rights to.
Drugs
Medical
Pharma
US regulator rejects Fortress Biotech’s experimental pediatric medicine
The US regulator has declined to approve an experimental pediatric drug of Fortress Biotech Inc., an American biotechnology company, due to certain production.
Drugs
Medical
Pharma
Pfizer inks deal with Trump to lower price of prescription drugs in US
Pfizer Inc., a US pharmaceutical company founded in 1849, has signed an agreement with the Trump administration to lower prices of prescription medicines.
Drugs
Health
Pharma
Pfizer to buy Matsera Inc. for $7.3 billion, eyes 4 anti-obesity drugs
Pfizer Inc. will buy Matsera Inc. for $7.3 billion to eye at least four experimental drugs in the rapidly growing obesity market after.
Drugs
Health
Pharma
GSK drug gets Britain’s nod to treat UTI patients 12 years and above
Britain’s Medicines and Healthcare products Regulatory Agency has approved GSK Plc’s Blujepa, an oral antibiotic pill to treat uncomplicated urinary tract infections in.
Drugs
Health
Pharma
Biogen’s drug to treat postnatal depression gets UK regulator’s nod
Biogen Inc., a US-based biotechnology company, got a nod from Britain’s medicines regulator for its drug to treat postnatal depression in adults.